FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marco Presta

Research Profile

Chemicals & Drugs

Anatomy

Disorders

Neovascularization, Pathologic

Living Beings

Mouse
Cattle

Physiology

Co-author Network

Publications

TOP 3
Roberto Ronca; Regina Tardanico; Chiara Tobia; william vermi; Patrizia Alessi; Mirella Belleri; Elisa Bonomi; Daniela Coltrini; Michela Corsini; Emanuela Di Salle; Cecilia Garlanda; Arianna Giacomini; Daria Leali; Marco Presta
Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
Daniela Coltrini; Emanuela Di Salle; Roberto Ronca; Chiara Testini; Mirella Belleri; Marco Presta
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR.
Cosetta Ravelli; Michela Corsini; stefania mitola; Marco Presta
Involvement of αvβ3 integrin in gremlin-induced angiogenesis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marco Presta (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Roberto Ronca; Regina Tardanico; Chiara Tobia; william vermi; Patrizia Alessi; Mirella Belleri; Elisa Bonomi; Daniela Coltrini; Michela Corsini; Emanuela Di Salle; Cecilia Garlanda; Arianna Giacomini; Daria Leali; Marco Presta
Long pentraxin-3 as an epithelial-stromal fibroblast growth factor-targeting inhibitor in prostate cancer.
The Journal of pathology 2013;230(2):228-38.
2013: Daniela Coltrini; Emanuela Di Salle; Roberto Ronca; Chiara Testini; Mirella Belleri; Marco Presta
Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR.
Angiogenesis 2013;16(2):469-77.
2013: Cosetta Ravelli; Michela Corsini; stefania mitola; Marco Presta
Involvement of αvβ3 integrin in gremlin-induced angiogenesis.
Angiogenesis 2013;16(1):235-43.
2013: Antonio Basile; Simona Berardi; Barbara Bottazzi; Paola Curci; Franco Dammacco; Annunziata De Luisi; Daniele Derudas; Paolo Ditonno; Maria Antonia Frassanito; Alberto Mantovani; Ilaria Marech; Michele Moschetta; Vincenzo Pavone; Marco Presta; Roberto Ria; Domenico Ribatti; Bernardo Rossini; Giorgina Specchia; Emanuele Angelucci; Angelo Vacca
Pentraxin 3 (PTX3) inhibits plasma cell/stromal cell cross-talk in the bone marrow of multiple myeloma patients.
The Journal of pathology 2013;229(1):87-98.
2012: Daniele Maiolo; stefania mitola; Giulio Oliviero; Marco Presta; Cosetta Ravelli; Antonella Bugatti; Laura Eleonora Depero; Daria Leali; Paolo Bergese
Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activation.
Journal of the American Chemical Society 2012;134(35):14573-9.
2012: Chiara Tobia; Pieter B van Loenen; Astrid E Alewijnse; Simone Buraschi; Paola Chiodelli; Patrizia Dell'Era; Efrem Foglia; stefania mitola; Stefania Nicoli; Marco Presta
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(9):e104-16.
2012: Chiara Urbinati; Elena Tanghetti; Mirella Belleri; Edoardo Giacopuzzi; Eugenio Monti; Marco Presta; Cosetta Ravelli; MARCO RUSNATI
Substrate-immobilized HIV-1 Tat drives VEGFR2/α(v)β(3)-integrin complex formation and polarization in endothelial cells.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(5):e25-34.
2012: Sandra Liekens; Beatrice Nico; Ghislain Opdenakker; María-Jesús Pérez-Pérez; Jan Balzarini; Mirella Belleri; Annelies Bronckaers; Antonella Bugatti; Elena Casanova; Alba Gigante; Domenico Ribatti; Rebecca Sienaert; Marco Presta
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.
Molecular cancer therapeutics 2012;11(4):817-29.
2012: Daria Leali; Giuseppe D Norata; Roberto Ronca; Marina Sironi; Mirella Belleri; Roberta Bianchi; Barbara Bottazzi; Daniela Coltrini; Anthony J Day; Emanuela Di Salle; Cecilia Garlanda; Antonio Inforzato; Marco Presta
Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis.
Arteriosclerosis, thrombosis, and vascular biology 2012;32(3):696-703.
2012: Katiuscia Pagano; Marco Presta; Antonella Bugatti; Giorgio Colombo; Chiara Foglieni; MARCO RUSNATI; Giulia Taraboletti; Simona Tomaselli; Rubben Torella; Lucia Zetta; Laura Ragona
Direct and allosteric inhibition of the FGF2/HSPGs/FGFR1 ternary complex formation by an antiangiogenic, thrombospondin-1-mimic small molecule.
PloS one 2012;7(5):e36990.
2011: Daria Leali; Giorgia Nardo; Roberto Ronca; Patrizia Alessi; Daniela Coltrini; Michela Corsini; Stefano Indraccolo; Marco Presta
Long pentraxin-3 inhibits FGF8b-dependent angiogenesis and growth of steroid hormone-regulated tumors.
Molecular cancer therapeutics 2011;10(9):1600-10.
2011: Chiara Tobia; Giulia De Sena; Marco Presta
Zebrafish embryo, a tool to study tumor angiogenesis.
The International journal of developmental biology 2011;55(4-5):505-9.
2010: Roberto Ronca; Patrizia Benzoni; Daria Leali; Chiara Urbinati; Mirella Belleri; Michela Corsini; Patrizia Alessi; Daniela Coltrini; Stefano Calza; Marco Presta; Patrizia Dell'Era
Antiangiogenic activity of a neutralizing human single-chain antibody fragment against fibroblast growth factor receptor 1.
Molecular cancer therapeutics 2010;9(12):3244-53.
2010: stefania mitola; Cosetta Ravelli; Emanuela Moroni; Valentina Salvi; Daria Leali; Kurt Ballmer-Hofer; Luca Zammataro; Marco Presta
Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.
Blood 2010;116(18):3677-80.
2010: Daria Leali; Roberta Bianchi; Antonella Bugatti; Stefania Nicoli; stefania mitola; Laura Ragona; Simona Tomaselli; Grazia Gallo; Sergio Catello; Vincenzo Rivieccio; Lucia Zetta; Marco Presta
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptide.
Journal of cellular and molecular medicine 2010;14(8):2109-21.
2010: Jo Vandercappellen; Sandra Liekens; Annelies Bronckaers; Samuel Noppen; Isabelle Ronsse; Chris Dillen; Mirella Belleri; stefania mitola; Paul Proost; Marco Presta; Sofie Struyf; Jo Van Damme
The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivo.
Molecular cancer research : MCR 2010;8(3):322-34.
2010: Antonella Naldini; Emilia Morena; Annalisa Pucci; Michela Pellegrini; Cosima T Baldari; Pier Giuseppe Pelicci; Marco Presta; Dragana Vukasovic; Fabio Carraro
The adaptor protein p66Shc is a positive regulator in the angiogenic response induced by hypoxic T cells.
Journal of leukocyte biology 2010;87(3):365-9.
2009: Patrizia Alessi; Daria Leali; Maura Camozzi; Annarita Cantelmo; Adriana Albini; Marco Presta
Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
European cytokine network 2009;20(4):225-34.
2009: Marco Presta; Dragana Vukasovic
New insights in the modulation of tumor angiogenesis.
European cytokine network 2009;20(4):157.
2009: Daniela Coltrini; Roberto Ronca; Mirella Belleri; Luciano Zardi; Stefano Indraccolo; Valentina Scarlato; Raffaella Giavazzi; Marco Presta
Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
The Journal of pathology 2009;219(4):455-62.
2009: Chiara Urbinati; Stefania Nicoli; Mauro Giacca; Guido David; Simona Fiorentini; Arnaldo Caruso; Massimo Alfano; Luca Cassetta; Marco Presta; MARCO RUSNATI
HIV-1 Tat and heparan sulfate proteoglycan interaction: a novel mechanism of lymphocyte adhesion and migration across the endothelium.
Blood 2009;114(15):3335-42.
2009: Roberto Ronca; Laura Gualandi; Elisabetta Crescini; Stefano Calza; Marco Presta; Patrizia Dell'Era
Fibroblast growth factor receptor-1 phosphorylation requirement for cardiomyocyte differentiation in murine embryonic stem cells.
Journal of cellular and molecular medicine 2009;13(8A):1489-98.
2009: Stefania Nicoli; Giulia De Sena; Marco Presta
Fibroblast growth factor 2-induced angiogenesis in zebrafish: the zebrafish yolk membrane (ZFYM) angiogenesis assay.
Journal of cellular and molecular medicine 2009;13(8B):2061-8.
2009: Germán Andrés; Daria Leali; stefania mitola; Daniela Coltrini; Maura Camozzi; Michela Corsini; Mirella Belleri; Emilio Hirsch; Reto A Schwendener; Gerhard Christofori; Antonio Alcamí; Marco Presta
A pro-inflammatory signature mediates FGF2-induced angiogenesis.
Journal of cellular and molecular medicine 2009;13(8B):2083-108.
2009: Marco Presta; Germán Andrés; Daria Leali; Patrizia Dell'Era; Roberto Ronca
Inflammatory cells and chemokines sustain FGF2-induced angiogenesis.
European cytokine network 2009;20(2):39-50.
2009: MARCO RUSNATI; Paolo Bergese; Antonella Bugatti; Laura E Depero; Daria Leali; stefania mitola; Marco Presta
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.
Sensors (Basel, Switzerland) 2009;9(8):6471-503.
2009: Roberto Ronca; Silvano Sozzani; Marco Presta; Patrizia Alessi
Delivering cytokines at tumor site: The immunocytokine-conjugated anti-EDB-fibronectin antibody case.
Immunobiology 2009;214(9-10):800-10.
2008: stefania mitola; Emanuela Moroni; Cosetta Ravelli; German Andres; Mirella Belleri; Marco Presta
Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm.
Blood 2008;112(4):1154-7.
2008: Stefania Nicoli; Chiara Tobia; Laura Gualandi; Giulia De Sena; Marco Presta
Calcitonin receptor-like receptor guides arterial differentiation in zebrafish.
Blood 2008;111(10):4965-72.
2008: Barbara Margosio; MARCO RUSNATI; Katiuscia Bonezzi; Blue-Leaf A Cordes; Douglas S Annis; Chiara Urbinati; Raffaella Giavazzi; Marco Presta; Dragana Vukasovic; Deane F Mosher; Giulia Taraboletti
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain.
The international journal of biochemistry & cell biology 2008;40(4):700-9.
2007: Silvano Sozzani; MARCO RUSNATI; Elena Riboldi; stefania mitola; Marco Presta
Dendritic cell-endothelial cell cross-talk in angiogenesis.
Trends in immunology 2007;28(9):385-92.
2007: Daria Leali; Emanuela Moroni; Federico Bussolino; Marco Presta
Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement.
The Journal of biological chemistry 2007;282(27):19676-84.
2007: Marco Presta; Maura Camozzi; Giovanni Salvatori; MARCO RUSNATI
Role of the soluble pattern recognition receptor PTX3 in vascular biology.
Journal of cellular and molecular medicine 2007;11(4):723-38.
2007: Dragana Vukasovic; Angelo Vacca; MARCO RUSNATI; Marco Presta
The discovery of basic fibroblast growth factor/fibroblast growth factor-2 and its role in haematological malignancies.
Cytokine & growth factor reviews 2007;18(3-4):327-34.
2007: Stefania Nicoli; Dragana Vukasovic; Franco Cotelli; Marco Presta
Mammalian tumor xenografts induce neovascularization in zebrafish embryos.
Cancer research 2007;67(7):2927-31.
2007: Helena Stabile; stefania mitola; Emanuela Moroni; Mirella Belleri; Stefania Nicoli; Daniela Coltrini; Francesco Peri; Antonello Pessi; Laura Orsatti; Fabio Talamo; Vincent Castronovo; David Waltregny; Franco Cotelli; Dragana Vukasovic; Marco Presta
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.
Blood 2007;109(5):1834-40.
2007: Stefania Nicoli; Marco Presta
The zebrafish/tumor xenograft angiogenesis assay.
Nature protocols 2007;2(11):2918-23.
2007: MARCO RUSNATI; Marco Presta
Fibroblast growth factors/fibroblast growth factor receptors as targets for the development of anti-angiogenesis strategies.
Current pharmaceutical design 2007;13(20):2025-44.
2006: Antonella Naldini; Daria Leali; Annalisa Pucci; Emilia Morena; Fabio Carraro; Beatrice Nico; Dragana Vukasovic; Marco Presta
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(7):4267-70.
2006: Maura Camozzi; MARCO RUSNATI; Antonella Bugatti; Barbara Bottazzi; Alberto Mantovani; Antonio Bastone; Antonio Inforzato; Silvia Vincenti; Luisa Bracci; Domenico mastroianni; Marco Presta
Identification of an antiangiogenic FGF2-binding site in the N terminus of the soluble pattern recognition receptor PTX3.
The Journal of biological chemistry 2006;281(32):22605-13.
2006: MARCO RUSNATI; Marco Presta
Extracellular angiogenic growth factor interactions: an angiogenesis interactome survey.
Endothelium : journal of endothelial cell research 2006;13(2):93-111.
2006: Dragana Vukasovic; Beatrice Nico; Angelo Vacca; Marco Presta
The gelatin sponge-chorioallantoic membrane assay.
Nature protocols 2006;1(1):85-91.
2006: stefania mitola; Mirella Belleri; Chiara Urbinati; Daniela Coltrini; Bianca Sparatore; Marco Pedrazzi; Edon Melloni; Marco Presta
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(1):12-5.
2005: Laura Belvisi; Teresa Riccioni; Marcella Marcellini; Loredana Vesci; Ilaria Chiarucci; Daniela Efrati; Donatella Potenza; Carlo Scolastico; Leonardo Manzoni; Katia Lombardo; M Antonietta Stasi; Augusto Orlandi; Alessandro Ciucci; Beatrice Nico; Dragana Vukasovic; Giuseppe Giannini; Marco Presta; Paolo Carminati; Claudio Pisano
Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Molecular cancer therapeutics 2005;4(11):1670-80.
2005: Chiara Urbinati; stefania mitola; Elena Tanghetti; Chandra Kumar; Johannes Waltenberger; Dragana Vukasovic; Marco Presta; MARCO RUSNATI
Integrin alphavbeta3 as a target for blocking HIV-1 Tat-induced endothelial cell activation in vitro and angiogenesis in vivo.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(11):2315-20.
2005: Elena Riboldi; Tiziana Musso; Emanuela Moroni; Chiara Urbinati; Sergio Bernasconi; MARCO RUSNATI; Luciano Adorini; Marco Presta; Silvano Sozzani
Cutting edge: proangiogenic properties of alternatively activated dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(5):2788-92.
2005: Chiara Urbinati; Antonella Bugatti; Mauro Giacca; David Schlaepfer; Marco Presta; MARCO RUSNATI
alpha(v)beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells.
Journal of cell science 2005;118(Pt 17):3949-58.
2005: Maura Camozzi; Serena Zacchigna; MARCO RUSNATI; Daniela Coltrini; Genaro A Ramirez Correa; Barbara Bottazzi; Alberto Mantovani; Mauro Giacca; Marco Presta
Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(9):1837-42.
2005: Mirella Belleri; Dragana Vukasovic; Stefania Nicoli; Franco Cotelli; Luca Forti; Vanio Vannini; Lucia A Stivala; Marco Presta
Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene.
Molecular pharmacology 2005;67(5):1451-9.
2005: Marco Presta; Patrizia Dell'Era; stefania mitola; Emanuela Moroni; Roberto Ronca; MARCO RUSNATI
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
Cytokine & growth factor reviews 2005;16(2):159-78.
2005: Stefania Nicoli; Claudio N Gilardelli; Ombretta Pozzoli; Marco Presta; Franco Cotelli
Regulated expression pattern of gremlin during zebrafish development.
Gene expression patterns : GEP 2005;5(4):539-44.
2005: Dragana Vukasovic; Angelo Vacca; Francesca Merchionne; Marco Presta
Antiangiogenesis by chemotherapeutic agents.
Mini reviews in medicinal chemistry 2005;5(3):313-7.
2005: Patrizia Dell'Era; Stefania Nicoli; Giuseppe Peri; Mariella Nieddu; Maria Grazia Ennas; Marco Presta
FGF2-induced upregulation of DNA polymerase-delta p12 subunit in endothelial cells.
Oncogene 2005;24(6):1117-21.
2005: Claudio Pisano; Concetta Aulicino; Loredana Vesci; Benito Casu; Annamaria Naggi; Giangiacomo Torri; Dragana Vukasovic; Mirella Belleri; MARCO RUSNATI; Marco Presta
Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist.
Glycobiology 2005;15(2):1C-6C.
2005: MARCO RUSNATI; Pasqua Oreste; Giorgio Zoppetti; Marco Presta
Biotechnological engineering of heparin/heparan sulphate: a novel area of multi-target drug discovery.
Current pharmaceutical design 2005;11(19):2489-99.
2005: Marco Presta; Pasqua Oreste; Giorgio Zoppetti; Mirella Belleri; Elena Tanghetti; Daria Leali; Chiara Urbinati; Antonella Bugatti; Roberto Ronca; Stefania Nicoli; Emanuela Moroni; Helena Stabile; Maura Camozzi; German Andrés Hernandez; stefania mitola; Patrizia Dell'Era; MARCO RUSNATI; Dragana Vukasovic
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(1):71-6.
2004: MARCO RUSNATI; Maura Camozzi; Emanuela Moroni; Barbara Bottazzi; Giuseppe Peri; Stefano Indraccolo; Alberto Amadori; Alberto Mantovani; Marco Presta
Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis.
Blood 2004;104(1):92-9.
2004: Chiara Urbinati; Antonella Bugatti; Pasqua Oreste; Giorgio Zoppetti; Johannes Waltenberger; stefania mitola; Dragana Vukasovic; Marco Presta; MARCO RUSNATI
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
FEBS letters 2004;568(1-3):171-7.
2004: Benito Casu; marco Guerrini; Sara Guglieri; Annamaria Naggi; Marta Perez; Giangiacomo Torri; Giuliana Cassinelli; Dragana Vukasovic; Paolo Carminati; Giuseppe Giannini; Sergio Penco; Claudio Pisano; Mirella Belleri; MARCO RUSNATI; Marco Presta
Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
Journal of medicinal chemistry 2004;47(4):838-48.
2003: Simona Taverna; Giulio Ghersi; Angela Ginestra; Salvatrice Rigogliuso; Sonia Pecorella; Giovanna Alaimo; Francesca Saladino; Vincenza Dolo; Patrizia Dell'Era; Antonio Pavan; Giuseppe Pizzolanti; Paolo Mignatti; Marco Presta; M Letizia Vittorelli
Shedding of membrane vesicles mediates fibroblast growth factor-2 release from cells.
The Journal of biological chemistry 2003;278(51):51911-9.
2003: Dragana Vukasovic; Angelo Vacca; Aldo Roccaro; Enrico Crivellato; Marco Presta
Erythropoietin as an angiogenic factor.
European journal of clinical investigation 2003;33(10):891-6.
2003: Patrizia Dell'Era; Roberto Ronca; Laura Coco; Stefania Nicoli; Marco Metra; Marco Presta
Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development.
Circulation research 2003;93(5):414-20.
2003: Alessandro Fanzani; Roberta Giuliani; Francesca Colombo; D Zizioli; Marco Presta; Augusto Preti; Sergio Marchesini
Overexpression of cytosolic sialidase Neu2 induces myoblast differentiation in C2C12 cells.
FEBS letters 2003;547(1-3):183-8.
2003: Daria Leali; Patrizia Dell'Era; Helena Stabile; Barbara Sennino; Ann F Chambers; Antonella Naldini; Silvano Sozzani; Beatrice Nico; Dragana Vukasovic; Marco Presta
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis.
Journal of immunology (Baltimore, Md. : 1950) 2003;171(2):1085-93.
2003: Raffaella Giavazzi; Barbara Sennino; Daniela Coltrini; Angela Garofalo; Romina Dossi; Roberto Ronca; Maria Pia Molinari Tosatti; Marco Presta
Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
The American journal of pathology 2003;162(6):1913-26.
2003: Dragana Vukasovic; Angelo Vacca; Beatrice Nico; Marco Presta; Luisa Roncali
Angiogenesis: basic and clinical aspects.
Italian journal of anatomy and embryology = Archivio italiano di anatomia ed embriologia 2003;108(1):1-24.
2003: Dragana Vukasovic; Angelo Vacca; Beatrice Nico; Enrico Crivellato; Giuseppe De Falco; Marco Presta
Cross talk between haematopoiesis and angiogenesis.
Advances in experimental medicine and biology 2003;522():25-36.
2003: Marco Presta; Daria Leali; Helena Stabile; Roberto Ronca; Maura Camozzi; Laura Coco; Emanuela Moroni; Sandra Liekens; MARCO RUSNATI
Heparin derivatives as angiogenesis inhibitors.
Current pharmaceutical design 2003;9(7):553-66.
2002: Benito Casu; marco Guerrini; Annamaria Naggi; Marta Perez; Giangiacomo Torri; Dragana Vukasovic; Paolo Carminati; Giuseppe Giannini; Sergio Penco; Claudio Pisano; Mirella Belleri; MARCO RUSNATI; Marco Presta
Short heparin sequences spaced by glycol-split uronate residues are antagonists of fibroblast growth factor 2 and angiogenesis inhibitors.
Biochemistry 2002;41(33):10519-28.
2002: Marco Presta; Mirella Belleri; Angelo Vacca; Dragana Vukasovic
Anti-angiogenic activity of the purine analog 6-thioguanine.
Leukemia 2002;16(8):1490-9.
2002: Dragana Vukasovic; Marco Presta
The role of fibroblast growth factor-2 in the vascularization of the chick embryo chorioallantoic membrane.
Journal of cellular and molecular medicine 2002;6(3):439-46.
2002: Patrizia Scapini; Lorella Nesi; Monica Morini; Elena Tanghetti; Mirella Belleri; Douglas M Noonan; Marco Presta; Adriana Albini; Marco A Cassatella
Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils.
Journal of immunology (Baltimore, Md. : 1950) 2002;168(11):5798-804.
2002: Elena Tanghetti; Roberto Ria; Patrizia Dell'Era; Chiara Urbinati; MARCO RUSNATI; Maria Grazia Ennas; Marco Presta
Biological activity of substrate-bound basic fibroblast growth factor (FGF2): recruitment of FGF receptor-1 in endothelial cell adhesion contacts.
Oncogene 2002;21(24):3889-97.
2002: Patrizia Dell'Era; Laura Coco; Roberto Ronca; Barbara Sennino; Marco Presta
Gene expression profile in fibroblast growth factor 2-transformed endothelial cells.
Oncogene 2002;21(15):2433-40.
2002: MARCO RUSNATI; Chiara Urbinati; Elena Tanghetti; Patrizia Dell'Era; Hugues Lortat-Jacob; Marco Presta
Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(7):4367-72.
2002: Emanuela Moroni; Patrizia Dell'Era; MARCO RUSNATI; Marco Presta
Fibroblast growth factors and their receptors in hematopoiesis and hematological tumors.
Journal of hematotherapy & stem cell research 2002;11(1):19-32.
2002: MARCO RUSNATI; Marco Presta
HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies.
Angiogenesis 2002;5(3):141-51.
2002: Dragana Vukasovic; Marco Presta
Pietro M. Gullino and angiogenesis.
Endothelium : journal of endothelial cell research 2002;9(4):227-30.
2001: Daria Leali; Mirella Belleri; Chiara Urbinati; Daniela Coltrini; Pasqua Oreste; Giorgio Zoppetti; Dragana Vukasovic; MARCO RUSNATI; Marco Presta
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.
The Journal of biological chemistry 2001;276(41):37900-8.
2001: Angelo Vacca; Roberto Ria; Marco Presta; Dragana Vukasovic; Monica Iurlaro; Francesca Merchionne; Elena Tanghetti; Franco Dammacco
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells.
Experimental hematology 2001;29(8):993-1003.
2001: Dragana Vukasovic; Beatrice Nico; Lucia Morbidelli; Sandra Donnini; Marina Ziche; Angelo Vacca; Luisa Roncali; Marco Presta
Cell-mediated delivery of fibroblast growth factor-2 and vascular endothelial growth factor onto the chick chorioallantoic membrane: endothelial fenestration and angiogenesis.
Journal of vascular research 2001;38(4):389-97.
2001: Sandra Liekens; Johan Neyts; Erik De Clercq; Erik Verbeken; Dragana Vukasovic; Marco Presta
Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir.
Cancer research 2001;61(13):5057-64.
2001: MARCO RUSNATI; Chiara Urbinati; Antonella Caputo; Laura Possati; H Lortat-Jacob; Mauro Giacca; Dragana Vukasovic; Marco Presta
Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat.
The Journal of biological chemistry 2001;276(25):22420-5.
2001: Patrizia Dell'Era; Mirella Belleri; Helena Stabile; M L Massardi; Dragana Vukasovic; Marco Presta
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells.
Oncogene 2001;20(21):2655-63.
2001: M Tyagi; MARCO RUSNATI; Marco Presta; Mauro Giacca
Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans.
The Journal of biological chemistry 2001;276(5):3254-61.
2001: MARCO RUSNATI; Chiara Urbinati; B Musulin; Dragana Vukasovic; A Albini; Douglas M Noonan; C Marchisone; Johannes Waltenberger; Marco Presta
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein.
Endothelium : journal of endothelial cell research 2001;8(1):65-74.
2001: Raffaella Giavazzi; Roberta Giuliani; Daniela Coltrini; Maria Rosa Bani; C Ferri; Barbara Sennino; M P Tosatti; A Stoppacciaro; Marco Presta
Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.
Cancer research 2001;61(1):309-17.
2000: Dragana Vukasovic; Angelo Vacca; Marco Presta
The discovery of angiogenic factors: a historical review.
General pharmacology 2000;35(5):227-31.
2000: MARCO RUSNATI; Giulia Taraboletti; Chiara Urbinati; Giovanni Tulipano; Roberta Giuliani; M P Molinari-Tosatti; Barbara Sennino; Mauro Giacca; M Tyagi; A Albini; Douglas M Noonan; Raffaella Giavazzi; Marco Presta
Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(13):1917-30.
2000: A Piccinotti; Giuliana Benaglia; Roberto Bresciani; D Zizioli; Marco Presta; Augusto Preti; Sergio Marchesini
Nerve growth factor induces sphingomyelin accumulation in pheochromocytoma cells.
FEBS letters 2000;472(1):143-7.
2000: Fulvia Gremo; Marco Presta
Role of fibroblast growth factor-2 in human brain: a focus on development.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 2000;18(2-3):271-9.
2000: Marco Presta; MARCO RUSNATI; Patrizia Dell'Era; Elena Tanghetti; Chiara Urbinati; Roberta Giuliani; Daria Leali
Examining new models for the study of autocrine and paracrine mechanisms of angiogenesis through FGF2-transfected endothelial and tumour cells.
Advances in experimental medicine and biology 2000;476():7-34.
1999: Dragana Vukasovic; A Gualandris; Mirella Belleri; L Massardi; Beatrice Nico; MARCO RUSNATI; Patrizia Dell'Era; Angelo Vacca; Luisa Roncali; Marco Presta
Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2.
The Journal of pathology 1999;189(4):590-9.
1999: Dragana Vukasovic; Daria Leali; Angelo Vacca; Roberta Giuliani; A Gualandris; Luisa Roncali; M L Nolli; Marco Presta
In vivo angiogenic activity of urokinase: role of endogenous fibroblast growth factor-2.
Journal of cell science 1999;112 ( Pt 23)():4213-21.
1999: MARCO RUSNATI; Giovanni Tulipano; D Spillmann; Elena Tanghetti; Pasqua Oreste; Giorgio Zoppetti; Mauro Giacca; Marco Presta
Multiple interactions of HIV-I Tat protein with size-defined heparin oligosaccharides.
The Journal of biological chemistry 1999;274(40):28198-205.
1999: Roberta Giuliani; M Bastaki; Daniela Coltrini; Marco Presta
Role of endothelial cell extracellular signal-regulated kinase1/2 in urokinase-type plasminogen activator upregulation and in vitro angiogenesis by fibroblast growth factor-2.
Journal of cell science 1999;112 ( Pt 15)():2597-606.
1999: Sandra Liekens; Daria Leali; Johan Neyts; Robert M Esnouf; MARCO RUSNATI; Patrizia Dell'Era; P C Maudgal; Erik De Clercq; Marco Presta
Modulation of fibroblast growth factor-2 receptor binding, signaling, and mitogenic activity by heparin-mimicking polysulfonated compounds.
Molecular pharmacology 1999;56(1):204-13.
1999: Marco Presta; MARCO RUSNATI; Mirella Belleri; L Morbidelli; M Ziche; Dragana Vukasovic
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.
Cancer research 1999;59(10):2417-24.
1999: Moritz Konerding; W Malkusch; B Klapthor; C van Ackern; E Fait; Sally A Hill; Charles S Parkins; D J Chaplin; Marco Presta; J Denekamp
Evidence for characteristic vascular patterns in solid tumours: quantitative studies using corrosion casts.
British journal of cancer 1999;80(5-6):724-32.
1999: Angelo Vacca; Dragana Vukasovic; Marco Presta; M Minischetti; Monica Iurlaro; Roberto Ria; Adriana Albini; Federico Bussolino; Franco Dammacco
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.
Blood 1999;93(9):3064-73.
1999: Dragana Vukasovic; Marco Presta; Angelo Vacca; Roberto Ria; Roberta Giuliani; Patrizia Dell'Era; Beatrice Nico; Luisa Roncali; Franco Dammacco
Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo.
Blood 1999;93(8):2627-36.
1999: MARCO RUSNATI; Elena Tanghetti; Chiara Urbinati; Giovanni Tulipano; S Marchesini; M Ziche; Marco Presta
Interaction of fibroblast growth factor-2 (FGF-2) with free gangliosides: biochemical characterization and biological consequences in endothelial cell cultures.
Molecular biology of the cell 1999;10(2):313-27.
1999: D Ribatti; B Nico; A Vacca; Luisa Roncali; Marco Presta
Endogenous and exogenous fibroblast growth factor-2 modulate wound healing in the chick embryo chorioallantoic membrane.
Angiogenesis 1999;3(1):89-95.
1999: Patrizia Dell'Era; M Mohammadi; Marco Presta
Different tyrosine autophosphorylation requirements in fibroblast growth factor receptor-1 mediate urokinase-type plasminogen activator induction and mitogenesis.
Molecular biology of the cell 1999;10(1):23-33.
1998: Alfredo Corallini; Monica Betti; MARCO RUSNATI; Diana Campioni; M Ciomei; F Sola; Nilla Calza; giorgio zauli; Marco Presta; Giuseppe Barbanti-Brodano; Antonella Caputo
Characterization of the effects of two polysulfonated distamycin A derivatives, PNU145156E and PNU153429, on HIV type 1 Tat protein.
AIDS research and human retroviruses 1998;14(17):1561-71.
1998: MARCO RUSNATI; Giovanni Tulipano; Chiara Urbinati; Elena Tanghetti; Roberta Giuliani; Mauro Giacca; M Ciomei; Alfredo Corallini; Marco Presta
The basic domain in HIV-1 Tat protein as a target for polysulfonated heparin-mimicking extracellular Tat antagonists.
The Journal of biological chemistry 1998;273(26):16027-37.
1998: Moritz Konerding; E Fait; Christiana Dimitropoulou; W Malkusch; C Ferri; Raffaella Giavazzi; Daniela Coltrini; Marco Presta
Impact of fibroblast growth factor-2 on tumor microvascular architecture. A tridimensional morphometric study.
The American journal of pathology 1998;152(6):1607-16.
1998: Marco Presta; Mirella Belleri; A Vecchi; Joseph Hesselgesser; Alberto Mantovani; Richard Horuk
Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation.
The Journal of biological chemistry 1998;273(14):7911-9.
1998: Valeria Sogos; L Balaci; Maria Grazia Ennas; Patrizia Dell'Era; Marco Presta; Fulvia Gremo
Developmentally regulated expression and localization of fibroblast growth factor receptors in the human muscle.
Developmental dynamics : an official publication of the American Association of Anatomists 1998;211(4):362-73.
1998: Angelo Vacca; Dragana Vukasovic; Monica Iurlaro; Adriana Albini; M Minischetti; Federico Bussolino; Antonio Pellegrino; Roberto Ria; MARCO RUSNATI; Marco Presta; V Vincenti; M Graziella Persico; Franco Dammacco
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis.
International journal of clinical & laboratory research 1998;28(1):55-68.
1998: Dragana Vukasovic; Mirella Bertossi; Beatrice Nico; Angelo Vacca; Roberto Ria; A Riva; Luisa Roncali; Marco Presta
Role of basic fibroblast growth factor in the formation of the capillary plexus in the chick embryo chorioallantoic membrane. An in situ hybridization, immunohistochemical and ultrastructural study.
Journal of submicroscopic cytology and pathology 1998;30(1):127-36.
1997: MARCO RUSNATI; Elena Tanghetti; Patrizia Dell'Era; A Gualandris; Marco Presta
alphavbeta3 integrin mediates the cell-adhesive capacity and biological activity of basic fibroblast growth factor (FGF-2) in cultured endothelial cells.
Molecular biology of the cell 1997;8(12):2449-61.
1997: Dragana Vukasovic; A Gualandris; M Bastaki; Angelo Vacca; Monica Iurlaro; Luisa Roncali; Marco Presta
New model for the study of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane: the gelatin sponge/chorioallantoic membrane assay.
Journal of vascular research 1997;34(6):455-63.
1997: A Gualandris; T Lopez Conejo; D Giunciuglio; A Albini; E Sabini; MARCO RUSNATI; Patrizia Dell'Era; Marco Presta
Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells.
Microvascular research 1997;53(3):254-60.
1997: MARCO RUSNATI; Daniela Coltrini; Diana Campioni; Elena Tanghetti; Alfredo Corallini; Giuseppe Barbanti-Brodano; Roberta Giuliani; Davide Gibellini; Marco Presta
Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice.
AIDS (London, England) 1997;11(6):727-36.
1997: MARCO RUSNATI; Daniela Coltrini; Pasqua Oreste; Giorgio Zoppetti; A Albini; Douglas M Noonan; F d'Adda di Fagagna; Mauro Giacca; Marco Presta
Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.
The Journal of biological chemistry 1997;272(17):11313-20.
1997: Dragana Vukasovic; Beatrice Nico; Mirella Bertossi; Luisa Roncali; Marco Presta
Basic fibroblast growth factor-induced angiogenesis in the chick embryo chorioallantoic membrane: an electron microscopy study.
Microvascular research 1997;53(2):187-90.
1997: M Bastaki; E E Nelli; Patrizia Dell'Era; MARCO RUSNATI; M P Molinari-Tosatti; S Parolini; R Auerbach; L P Ruco; Laura Possati; Marco Presta
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(3):454-64.
1996: T Di Pucchio; Maria Grazia Ennas; Marco Presta; Giuliana M Lauro
Basic fibroblast growth factor modulates in vitro differentiation of human fetal microglia.
Neuroreport 1996;7(15-17):2813-7.
1996: S Parolini; D Flagiello; A Cinquetti; R Gozzi; S Cristini; J Cappiello; Piero Nicolai; MARCO RUSNATI; Marco Presta; M M Tosatti
Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx.
British journal of cancer 1996;74(8):1168-74.
1996: Alfredo Corallini; Diana Campioni; C Rossi; Adriana Albini; Laura Possati; MARCO RUSNATI; Giancarlo Gazzanelli; Roberto Benelli; L Masiello; V Sparacciari; Marco Presta; Ferdinando Mannello; G Fontanini; Giuseppe Barbanti-Brodano
Promotion of tumour metastases and induction of angiogenesis by native HIV-1 Tat protein from BK virus/tat transgenic mice.
AIDS (London, England) 1996;10(7):701-10.
1996: MARCO RUSNATI; Patrizia Dell'Era; Chiara Urbinati; Elena Tanghetti; M L Massardi; Y Nagamine; E Monti; Marco Presta
A distinct basic fibroblast growth factor (FGF-2)/FGF receptor interaction distinguishes urokinase-type plasminogen activator induction from mitogenicity in endothelial cells.
Molecular biology of the cell 1996;7(3):369-81.
1996: A Gualandris; MARCO RUSNATI; Mirella Belleri; E E Nelli; M Bastaki; M P Molinari-Tosatti; F Bonardi; S Parolini; Adriana Albini; Lucia Morbidelli; Marina Ziche; Alfredo Corallini; L Possati; A Vacca; Dragana Vukasovic; Marco Presta
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1996;7(2):147-60.
1996: Adriana Albini; Roberto Benelli; Marco Presta; MARCO RUSNATI; M Ziche; Anna Rubartelli; G Paglialunga; Federico Bussolino; D Noonan
HIV-tat protein is a heparin-binding angiogenic growth factor.
Oncogene 1996;12(2):289-97.
1995: Daniela Coltrini; A Gualandris; E E Nelli; S Parolini; M P Molinari-Tosatti; N Quarto; Marina Ziche; R Giavazzi; Marco Presta
Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action.
Cancer research 1995;55(20):4729-38.
1995: Marco Colasanti; T Di Pucchio; Tiziana Persichini; Valeria Sogos; Marco Presta; Giuliana M Lauro
Inhibition of inducible nitric oxide synthase mRNA expression by basic fibroblast growth factor in human microglial cells.
Neuroscience letters 1995;195(1):45-8.
1995: Dragana Vukasovic; Chiara Urbinati; Beatrice Nico; MARCO RUSNATI; Luisa Roncali; Marco Presta
Endogenous basic fibroblast growth factor is implicated in the vascularization of the chick embryo chorioallantoic membrane.
Developmental biology 1995;170(1):39-49.
1995: A Gualandris; Marco Presta
Transcriptional and posttranscriptional regulation of urokinase-type plasminogen activator expression in endothelial cells by basic fibroblast growth factor.
Journal of cellular physiology 1995;162(3):400-9.
1995: Marco Presta; Chiara Urbinati; Patrizia Dell'Era; Giuliana M Lauro; Valeria Sogos; L Balaci; Maria Grazia Ennas; Fulvia Gremo
Expression of basic fibroblast growth factor and its receptors in human fetal microglia cells.
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 1995;13(1):29-39.
1994: L Balaci; Marco Presta; Maria Grazia Ennas; Patrizia Dell'Era; Valeria Sogos; Giuliana M Lauro; Fulvia Gremo
Differential expression of fibroblast growth factor receptors by human neurones, astrocytes and microglia.
Neuroreport 1994;6(1):197-200.
1994: T Zavanella; G Radaelli; P Girotti; E Arias; L Ameri; Marco Presta; Giovanna Mazzoleni; G Ragnotti
Evaluation of the tumor-promoting activity of two beta-adrenoreceptor blocking agents, propranolol and atenolol, in liver of Fischer 344 rats.
Carcinogenesis 1994;15(11):2531-9.
1994: Daniela Coltrini; MARCO RUSNATI; Giorgio Zoppetti; Pasqua Oreste; G Grazioli; Annamaria Naggi; Marco Presta
Different effects of mucosal, bovine lung and chemically modified heparin on selected biological properties of basic fibroblast growth factor.
The Biochemical journal 1994;303 ( Pt 2)():583-90.
1994: A Gualandris; Chiara Urbinati; MARCO RUSNATI; Marina Ziche; Marco Presta
Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF.
Journal of cellular physiology 1994;161(1):149-59.
1994: MARCO RUSNATI; Daniela Coltrini; P Caccia; Patrizia Dell'Era; Giorgio Zoppetti; Pasqua Oreste; B Valsasina; Marco Presta
Distinct role of 2-O-, N-, and 6-O-sulfate groups of heparin in the formation of the ternary complex with basic fibroblast growth factor and soluble FGF receptor-1.
Biochemical and biophysical research communications 1994;203(1):450-8.
1993: Daniela Coltrini; MARCO RUSNATI; Giorgio Zoppetti; Pasqua Oreste; A Isacchi; P Caccia; L Bergonzoni; Marco Presta
Biochemical bases of the interaction of human basic fibroblast growth factor with glycosaminoglycans. New insights from trypsin digestion studies.
European journal of biochemistry / FEBS 1993;214(1):51-8.
1993: M Statuto; Maria Grazia Ennas; GIUSEPPE ZAMBONI; Franco Bonetti; maurizio pea; F Bernardello; A Pozzi; MARCO RUSNATI; A Gualandris; Marco Presta
Basic fibroblast growth factor in human pheochromocytoma: a biochemical and immunohistochemical study.
International journal of cancer. Journal international du cancer 1993;53(1):5-10.
1993: A Gualandris; Daniela Coltrini; L Bergonzoni; A Isacchi; S Tenca; B Ginelli; Marco Presta
The NH2-terminal extension of high molecular weight forms of basic fibroblast growth factor (bFGF) is not essential for the binding of bFGF to nuclear chromatin in transfected NIH 3T3 cells.
Growth factors (Chur, Switzerland) 1993;8(1):49-60.
1993: MARCO RUSNATI; Chiara Urbinati; Marco Presta
Internalization of basic fibroblast growth factor (bFGF) in cultured endothelial cells: role of the low affinity heparin-like bFGF receptors.
Journal of cellular physiology 1993;154(1):152-61.
1993: Marco Presta; A Gualandris; Chiara Urbinati; MARCO RUSNATI; Daniela Coltrini; A Isacchi; P Caccia; L Bergonzoni
Subcellular localization and biological activity of M(r) 18,000 basic fibroblast growth factor: site-directed mutagenesis of a putative nuclear translocation sequence.
Growth factors (Chur, Switzerland) 1993;9(4):269-78.
1992: Marco Presta; M Statuto; A Isacchi; P Caccia; A Pozzi; A Gualandris; MARCO RUSNATI; L Bergonzoni; P Sarmientos
Structure-function relationship of basic fibroblast growth factor: site-directed mutagenesis of a putative heparin-binding and receptor-binding region.
Biochemical and biophysical research communications 1992;185(3):1098-107.
1992: Marco Presta; MARCO RUSNATI; Chiara Urbinati; Elena Tanghetti; M Statuto; A Pozzi; A Gualandris; G Ragnotti
Basic fibroblast growth factor bound to cell substrate promotes cell adhesion, proliferation, and protease production in cultured endothelial cells.
EXS 1992;61():205-9.
1992: A Isacchi; L Bergonzoni; M Statuto; R Chiesa; MARCO RUSNATI; Marco Presta; G Ragnotti; P Sarmientos
Activation of the tyrosine kinase receptor is not sufficient for the full biological activity of bFGF.
EXS 1992;61():101-6.
1991: Marco Presta; MARCO RUSNATI; Chiara Urbinati; A Sommer; G Ragnotti
Biologically active synthetic fragments of human basic fibroblast growth factor (bFGF): identification of two Asp-Gly-Arg-containing domains involved in the mitogenic activity of bFGF in endothelial cells.
Journal of cellular physiology 1991;149(3):512-24.
1991: Marco Presta; L Tiberio; MARCO RUSNATI; Patrizia Dell'Era; G Ragnotti
Basic fibroblast growth factor requires a long-lasting activation of protein kinase C to induce cell proliferation in transformed fetal bovine aortic endothelial cells.
Cell regulation 1991;2(9):719-26.
1991: A Isacchi; M Statuto; R Chiesa; L Bergonzoni; MARCO RUSNATI; P Sarmientos; G Ragnotti; Marco Presta
A six-amino acid deletion in basic fibroblast growth factor dissociates its mitogenic activity from its plasminogen activator-inducing capacity.
Proceedings of the National Academy of Sciences of the United States of America 1991;88(7):2628-32.
1991: Patrizia Dell'Era; Marco Presta; G Ragnotti
Nuclear localization of endogenous basic fibroblast growth factor in cultured endothelial cells.
Experimental cell research 1991;192(2):505-10.
1991: A Isacchi; L Bergonzoni; M Statuto; MARCO RUSNATI; R Chiesa; P Caccia; P Sarmientos; Marco Presta; G Ragnotti
A mutant of basic fibroblast growth factor that has lost the ability to stimulate plasminogen activator synthesis in endothelial cells.
Annals of the New York Academy of Sciences 1991;638():369-77.
1991: Marco Presta; MARCO RUSNATI; Chiara Urbinati; M Statuto; G Ragnotti
Functional domains of basic fibroblast growth factor. Possible role of Asp-Gly-Arg sequences in the mitogenic activity of bFGF.
Annals of the New York Academy of Sciences 1991;638():361-8.
1990: Marco Presta; R Chiesa; F Legati; B Ginelli; S Tenca; G Ragnotti
Liver genotoxic activity of an epoxide derivative of the hepatocarcinogenic beta-blocker DL-ZAMI 1305.
Cancer letters 1990;55(1):61-6.
1990: Marco Presta; Maria Grazia Ennas; Silvia Torelli; G Ragnotti; Fulvia Gremo
Synthesis of urokinase-type plasminogen activator and of type-1 plasminogen activator inhibitor in neuronal cultures of human fetal brain: stimulation by phorbol ester.
Journal of neurochemistry 1990;55(5):1647-54.
1990: Silvia Torelli; Patrizia Dell'Era; Maria Grazia Ennas; Valeria Sogos; Fulvia Gremo; G Ragnotti; Marco Presta
Basic fibroblast growth factor in neuronal cultures of human fetal brain.
Journal of neuroscience research 1990;27(1):78-83.
1990: J A Maier; MARCO RUSNATI; G Ragnotti; Marco Presta
Characterization of a Mr 20,000 basic fibroblast growth factor-like protein secreted by normal and transformed fetal bovine aortic endothelial cells.
Experimental cell research 1990;186(2):354-61.
1990: Marco Presta; F Legati; R Chiesa; Patrizia Dell'Era; G Ragnotti
Chemical structure and genotoxic activity of the hepatocarcinogenic beta-blocker DL-ZAMI 1305.
Carcinogenesis 1990;11(2):261-5.
1990: MARCO RUSNATI; G Casarotti; S Pecorelli; G Ragnotti; Marco Presta
Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium.
Growth factors (Chur, Switzerland) 1990;3(4):299-307.
1989: Marco Presta; J A Maier; MARCO RUSNATI; G Ragnotti
Basic fibroblast growth factor: production, mitogenic response, and post-receptor signal transduction in cultured normal and transformed fetal bovine aortic endothelial cells.
Journal of cellular physiology 1989;141(3):517-26.
1989: Marco Presta; M Statuto; MARCO RUSNATI; Patrizia Dell'Era; G Ragnotti
Characterization of a Mr 25,000 basic fibroblast growth factor form in adult, regenerating, and fetal rat liver.
Biochemical and biophysical research communications 1989;164(3):1182-9.
1989: Marco Presta; J A Maier; G Ragnotti
The mitogenic signaling pathway but not the plasminogen activator-inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells.
The Journal of cell biology 1989;109(4 Pt 1):1877-84.
1989: Marco Presta; J A Maier; MARCO RUSNATI; G Ragnotti
Basic fibroblast growth factor is released from endothelial extracellular matrix in a biologically active form.
Journal of cellular physiology 1989;140(1):68-74.
1989: J A Maier; Marco Presta; G Ragnotti
Induction of plasminogen activator activity by phorbol ester in transformed fetal bovine aortic endothelial cells. Possible independence from protein kinase C.
Biochemical and biophysical research communications 1989;160(2):682-91.
1988: Marco Presta; J A Maier; MARCO RUSNATI; D Moscatelli; G Ragnotti
Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor beta.
Cancer research 1988;48(22):6384-9.
1987: G Ragnotti; Marco Presta; J A Maier; MARCO RUSNATI; Giovanna Mazzoleni; F Legati; R Chiesa; Marina Braga; D Calovini
Critical role of gonadal hormones on the genotoxic activity of the hepatocarcinogen DL-ZAMI 1305.
Cancer letters 1987;36(3):253-61.
1986: N Pacces; Marina Braga; T Zavanella; Marco Presta; G Ragnotti
Further studies on the tumor-initiating activity of the beta-blocker DL-ZAMI 1305.
Toxicologic pathology 1986;14(4):470-6.
1985: L Riboni; Marco Presta; S Ziliani; C Mazzocchi; G Braga; Giovanna Mazzoleni; G Ragnotti
Inhibition of DNA and RNA synthesis in rat liver nuclei by oncogenic and non-oncogenic beta-blockers.
Toxicologic pathology 1985;13(1):18-25.
1984: Marco Presta; C Mazzocchi; S Ziliani; T Zavanella; G Ragnotti
Early liver alterations induced by the sex-dependent hepatocarcinogen beta-blocker ZAMI 1305.
Chemico-biological interactions 1984;52(2):203-12.
1984: T Zavanella; Marco Presta; G Braga; E Dimito; C Mazzocchi; S Ziliani; G Ragnotti
Tumor-initiating activity of the beta-blocker ZAMI 1305 in the liver of the female Wistar rat.
Cancer letters 1984;25(1):1-11.
1984: S Ziliani; Marco Presta; C Mazzocchi; Giovanna Mazzoleni; D Calovini; G Ragnotti
Age-dependent, seasonal and daily variations of the DNA damaging capacity of the hepatocarcinogen ZAMI 1305 in female rat liver.
Cancer letters 1984;23(3):245-51.
1984: C Mazzocchi; Marco Presta; S Ziliani; A Romano; G Ragnotti
Optical isomers of the hepatocarcinogenic beta-blocker ZAMI 1305: influence on nucleic acids synthesis and DNA integrity.
Chemico-biological interactions 1984;50(1):77-86.
1984: Marco Presta; T Zavanella; C Mazzocchi; S Ziliani; Giovanna Mazzoleni; D Calovini; Marina Braga; G Ragnotti
Thyroid and chemical hepatocarcinogenesis: further insights from the hepatocarcinogen ZAMI 1305.
Toxicologic pathology 1984;12(1):49-55.
1983: T Zavanella; Marco Presta; G Ragnotti
Thyroid modifications in male and female rats treated with the hepatocarcinogen beta-blocker ZAMI 1305.
Cancer letters 1983;19(3):293-9.
1983: Marco Presta; C Mazzocchi; S Ziliani; G Ragnotti
In vitro and in vivo DNA damage of male and female rat liver nuclei by oncogenic and nononcogenic beta blockers.
Journal of the National Cancer Institute 1983;70(4):747-52.
1982: G Ragnotti; Marco Presta; L Riboni; T Zavanella
Liver tumors induced by a new beta-adrenoreceptor blocking agent in female rats.
Journal of the National Cancer Institute 1982;68(4):669-72.
1982: Marco Presta; L Riboni; G Ragnotti
Inhibition in vitro of yeast DNA polymerase I activity by beta-blockers.
Bioscience reports 1982;2(1):55-62.